Lysosomal reduced thiols are essential for mouse embryonic development
- PMID: 40892915
- PMCID: PMC12435214
- DOI: 10.1073/pnas.2427125122
Lysosomal reduced thiols are essential for mouse embryonic development
Abstract
While it has been appreciated for decades that lysosomes can import cysteine, its significance for whole-organism physiology has remained uncertain. Recent work identified MFSD12 as a transmembrane protein required for cysteine import into lysosomes (and melanosomes), enabling genetic interrogation of this pathway. Here, we show that Mfsd12 knockout mice die between embryonic days 10.5 and 12.5, indicating that MFSD12 is essential for organogenesis. Mfsd12 loss results in the expression of genes involved in cellular stress and thiol metabolism and likely disproportionately affects the erythroid, myeloid, and neuronal lineages. Within lysosomes, imported cysteine is largely oxidized to cystine, which is exported to the cytosol by the cystinosin (CTNS) transporter. However, unlike Mfsd12, loss of Ctns is compatible with viability, suggesting that the essential role of MFSD12 lies not in supplying cystine to the cytosol, but in providing reduced cysteine within the lysosomal lumen. Supporting this model, maternal treatment with cysteamine-a lysosome-penetrant thiol-rescued the development of Mfsd12 knockout embryos, yielding viable adult offspring. These findings establish lysosomal thiol import as a critical metabolic pathway and provide genetic tools to further clarify its physiological and biochemical roles.
Keywords: MFSD12; cysteine; lysosome; redox.
Conflict of interest statement
Competing interests statement:D.E.F. discloses ownership and consulting relationships with Soltego, Tasca, Swiss Rockets, Coherent Medicines, AME Therapeutics, and Biocoz, and a consulting relationship with Pierre Fabre. D.E.F. has a financial interest in Soltego, a company developing salt inducible kinase inhibitors for topical skin-darkening treatments that might be used for a broad set of human applications. The interests of D.E.F. were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict-of interest policies. C.H.A. and D.M.S. are listed on a patent (US20230103549A1) related to the work described here.
Figures
Update of
-
Lysosomal reduced thiols are essential for mouse embryonic development.bioRxiv [Preprint]. 2024 Dec 26:2024.12.26.630348. doi: 10.1101/2024.12.26.630348. bioRxiv. 2024. Update in: Proc Natl Acad Sci U S A. 2025 Sep 9;122(36):e2427125122. doi: 10.1073/pnas.2427125122. PMID: 39764028 Free PMC article. Updated. Preprint.
References
-
- Settembre C., Perera R. M., Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology. Nat. Rev. Mol. Cell Biol. 25, 223–245 (2024). - PubMed
-
- Ballabio A., Bonifacino J. S., Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat. Rev. Mol. Cell Biol. 21, 101–118 (2020). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
